EE+ POEM Archive
Dual antiplatelet therapy with either clopidogrel or ticagrelor is more effective than aspirin alone in preventing recurrent stroke
Dual antiplatelet therapy with either clopidogrel or ticagrelor is more effective than aspirin alone in preventing recurrent stroke is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Dual Antiplatelet Therapy With Either Clopidogrel or Ticagrelor Is More Effective Than Aspirin Alone in Preventing Recurrent Stroke." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315604/all/Dual_antiplatelet_therapy_with_either_clopidogrel_or_ticagrelor_is_more_effective_than_aspirin_alone_in_preventing_recurrent_stroke.
Dual antiplatelet therapy with either clopidogrel or ticagrelor is more effective than aspirin alone in preventing recurrent stroke. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315604/all/Dual_antiplatelet_therapy_with_either_clopidogrel_or_ticagrelor_is_more_effective_than_aspirin_alone_in_preventing_recurrent_stroke. Accessed May 27, 2022.
Dual antiplatelet therapy with either clopidogrel or ticagrelor is more effective than aspirin alone in preventing recurrent stroke. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315604/all/Dual_antiplatelet_therapy_with_either_clopidogrel_or_ticagrelor_is_more_effective_than_aspirin_alone_in_preventing_recurrent_stroke
Dual Antiplatelet Therapy With Either Clopidogrel or Ticagrelor Is More Effective Than Aspirin Alone in Preventing Recurrent Stroke [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2022 May 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315604/all/Dual_antiplatelet_therapy_with_either_clopidogrel_or_ticagrelor_is_more_effective_than_aspirin_alone_in_preventing_recurrent_stroke.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dual antiplatelet therapy with either clopidogrel or ticagrelor is more effective than aspirin alone in preventing recurrent stroke
ID - 1315604
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315604/all/Dual_antiplatelet_therapy_with_either_clopidogrel_or_ticagrelor_is_more_effective_than_aspirin_alone_in_preventing_recurrent_stroke
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
